TNE:ASXTechnology One Limited Analysis
Data as of 2026-06-12 - not real-time
A$31.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technology One Limited is trading at AUD 31.30, which is more than three times its DCF‑derived fair value of AUD 10.42, and its trailing PE of 72.8x far exceeds the software industry average of 36.5x, signaling a pronounced overvaluation. Revenue growth of 11.5% YoY and a robust operating margin of 27% underline solid underlying fundamentals, while a ROE of 33.5% and free cash flow generation of AUD 152 million demonstrate strong cash conversion. Recent half‑year results beat expectations, prompting a 7% share price rebound and positive sentiment in the market. However, the stock’s 30‑day volatility of 38% and a beta below 1 (≈0.6) indicate heightened price swings with limited market correlation. The technical picture remains bullish – price sits above the 20‑day (30.59) and 50‑day (29.36) SMAs, MACD is bullish, and RSI is neutral at 56. Dividend yield sits at 0.89% with a payout ratio of 62%, supported by ample cash and low debt.
Given the mix of strong earnings momentum and elevated valuation, short‑term traders may capitalize on the bullish technical setup, but the valuation gap tempers enthusiasm for longer horizons. Medium‑term outlook is mixed as the stock must justify its premium through sustained growth, while the dividend appears sustainable. Over the long term, the company’s high ROE, cash generation, and strategic SaaS positioning could vindicate a higher multiple, provided growth remains resilient and market sentiment stabilises.
Given the mix of strong earnings momentum and elevated valuation, short‑term traders may capitalize on the bullish technical setup, but the valuation gap tempers enthusiasm for longer horizons. Medium‑term outlook is mixed as the stock must justify its premium through sustained growth, while the dividend appears sustainable. Over the long term, the company’s high ROE, cash generation, and strategic SaaS positioning could vindicate a higher multiple, provided growth remains resilient and market sentiment stabilises.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technicals with price above key SMAs
- Earnings beat and 7% price rebound
- Stable volume supporting liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Significant overvaluation relative to DCF and peers
- High volatility and modest beta
- Need for continued earnings acceleration to justify premium
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong ROE and free cash flow generation
- Sustainable dividend with low payout risk
- Strategic position in enterprise SaaS market
Key Metrics & Analysis
Financial Health
Revenue Growth11.50%
Profit Margin22.41%
P/E Ratio72.8
ROE33.53%
ROA14.58%
Debt/Equity11.55
P/B Ratio23.9
Op. Cash FlowA$305.7M
Free Cash FlowA$152.0M
Industry P/E36.5
Technical Analysis
TrendNeutral
RSI56.3
SupportA$27.00
ResistanceA$33.15
MA 20A$30.59
MA 50A$29.36
MA 200A$30.60
MACDBullish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair ValueA$10.42
Target PriceA$31.16
Upside/Downside-0.45%
GradeOvervalued
TypeGrowth
Dividend Yield0.89%
Risk Assessment
Beta0.83
Volatility38.47%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.